![KP1019, A New Redox-Active Anticancer Agent – Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients]()
KP1019, A New Redox-Active Anticancer Agent – Preclinical Development and Results of a Clinical Phase I Study in Tumor PatientsChristian G. Hartinger; Michael A. Jakupec; Stefanie Zorbas-Seifried; Michael Groessl; Alexander Egger; Walter Berger; Haralabos Zorbas; Paul J. Dyson; Bernhard K. Keppler · 2008